ClinicalTrials.Veeva

Menu

Human Epididymis Protein 4 in Normal Menstruating Women

Women and Infants Hospital of Rhode Island logo

Women and Infants Hospital of Rhode Island

Status

Unknown

Conditions

Healthy Premenopausal Women

Treatments

Other: blood draws

Study type

Observational

Funder types

Other
Industry

Identifiers

NCT01337999
10-0127

Details and patient eligibility

About

The purpose of this study is to determine if Human Epididymis Protein 4 (HE-4) levels vary during the menstrual cycles in ovulatory women. HE-4 is a sensitive serological marker that is elevated in certain ovarian and endometrial cancers and can aid in the diagnosis of these malignant conditions. In order to optimize the utility of HE4 as a tumor marker in premenopausal women, its expression in the normal menstrual cycle needs to be characterized. We hypothesize that HE-4 levels do not vary in the menstrual cycle.

Enrollment

60 estimated patients

Sex

Female

Ages

18 to 45 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • women age 18-45 years old
  • regular menstrual cycles (every 25-35 days)
  • normal BMI (19-25)
  • no hormonal contraception in the two menstrual cycles prior to enrollment

Exclusion criteria

  • pregnancy
  • pelvic mass

Trial design

60 participants in 1 patient group

HE-4 levels, healthy premenopausal women
Treatment:
Other: blood draws

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems